Top-News
Industrie/Investitionsgüter Schweiz

Lonza Group Unsp. ADR 1/10 News

Aktie
WKN:  A0YF75 ISIN:  US54338V1017 US-Symbol:  LZAGY
52,50 €
-0,50 €
-0,94%
14:23:50 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
741,89 Mio.
Marktkapitalisierung *
39,54 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 13.09.2022

Lonza Group Unsp. ADR 1/10 News

02.05.24 - PR Newswire
NeuroSense Announces First Quarter 2024 Business Update
NeuroSense Announces First Quarter 2024 Business Update PR Newswire
13.09.23 - PR Newswire
ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products
ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products PR Newswire
13.09.23 - PR Newswire
ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products
ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products PR Newswire
09.06.21 - Der Aktionär TV
Michel Doepke: "Mein Favorit bei den Impfstoff-Aktien bleibt.."
Von "Welchen Impfstoff hast du bekommen?" hin zu "Welche Impfstoff-​Aktie hast du im Depot?". Seit der Corona-​Pandemie profitiert nicht nur die Bevölkerung von den Vakzinen, ...
06.04.21 - Der Aktionär TV
Börsenplatz Zürich: Zusammenarbeit mit Moderna - Lonza auch nach Corona stark aufgestellt?
Corona bleibt omnipräsent, die Krise ist nach wie vor nicht gelöst. Für Hoffnung in der Pandemie sorgt unter anderem Lonza. Der Chemie- und Pharmakonzern aus der Schweiz hat ...
20.08.20 - PR Newswire
IsoPlexis and Lonza Collaborate to Enable the Next Generation of Precision Cell Therapy Manufacturing
IsoPlexis and Lonza Collaborate to Enable the Next Generation of Precision Cell Therapy Manufacturing - Lonza to utilize of IsoPlexis' IsoLight® automated proteomics platform - ...
05.11.19 - PR Newswire
Lonza Partners with Cryoport and Strengthens its 'Vein-to-vein' Delivery Network in Cell & Gene Therapy
Lonza Partners with Cryoport and Strengthens its 'Vein-​to-vein' Delivery Network in Cell & Gene Therapy - Cryoport as a preferred partner for Lonza in the transport and delivery of ...
21.12.18 - PR Newswire
Neptune to Expand Manufacturing Capability to Offer Cannabis Oil Capsules in Canada
Neptune to Expand Manufacturing Capability to Offer Cannabis Oil Capsules in Canada PR Newswire
10.04.18 - PR Newswire
Lonza Opens World's Largest Dedicated Cell and-Gene-Therapy Manufacturing Facility in Pearland, Greater Houston, TX (USA)
Lonza Opens World's Largest Dedicated Cell and-​Gene-Therapy Manufacturing Facility in Pearland, Greater Houston, TX (USA) - First-​of-its-kind, state-​of-the-art manufacturing ...
15.12.16 - PR Newswire
Lonza to Acquire Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries
Lonza to Acquire Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries PR Newswire
07.12.16 - PR Newswire
Lonza to Divest Peptides Business and Operations in Braine-l'Alleud, Belgium, to PolyPeptide
Lonza to Divest Peptides Business and Operations in Braine-l'Alleud, Belgium, to PolyPeptide PR Newswire
07.12.16 - PR Newswire
Lonza to Divest Peptides Business and Operations in Braine-l'Alleud, Belgium, to PolyPeptide
Lonza to Divest Peptides Business and Operations in Braine-l'Alleud, Belgium, to PolyPeptide PR Newswire

Newssuche

Videos

newspaper
08:55 Uhr +14,15%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »